Updates

Breakthroughs In Biotechnology
Innovations In Business Development

EV Biologics is advancing the science, medicine and enterprise of extracellular vesicles every day. Stay up to date with the latest news in biotechnology and our business development.

Press Releases

EV Biologics NFT Dividend Information

EV Biologics Corp, OTC PINK:YECO, today updated shareholders with further details about its NFT Warrant Dividend. Attached is a preliminary image from the 3D animation still under development that will be issued as an NFT dividend Daniel Mckinney CEO said:...

EV News

The Times of Israel / TOI Staff / 5 February 2021